Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Braun L M, Giesler S, Andrieux G, Riemer R, Talvard-Balland N, Duquesne S, Rückert T, Unger S, Kreutmair S, Zwick M, Follo M, Hartmann A, Osswald N, Melchinger W, Chapman S, Hutchinson J A, Haferkamp S, Torster L, Kött J, Gebhardt C, Hellwig D, Karantzelis N, Wallrabenstein T, Lowinus T, Yücel M, Brehm N, Rawluk J, Pfeifer D, Bronsert P, Rogg M, Mattern S, Heikenwälder M, Fusco S, Malek N P, Singer S, Schmitt-Graeff A, Ceteci F, Greten F R, Blazar B R, Boerries M, Köhler N, Duyster J, Ihorst G, Lassmann S, Keye P, Minguet S, Schadendorf D, Ugurel S, Rafei-Shamsabadi D, Thimme R, Hasselblatt P, Bengsch B, Schell C, Pearce E L, Meiss F, Becher B, Funke-Lorenz C, Placke J-M, Apostolova P, Zeiser R.
Cancer Cell. 2025 Feb 10. doi: 10.1016/j.ccell.2025.01.004.